SB15 (2017) Detail

Relative to the law regarding therapeutic use of cannabis.


SB 15 - VERSION ADOPTED BY BOTH BODIES

 

 

2017 SESSION

17-0516

01/04

 

SENATE BILL 15

 

AN ACT relative to the law regarding therapeutic use of cannabis.

 

SPONSORS: Sen. Reagan, Dist 17

 

COMMITTEE: Health and Human Services

 

-----------------------------------------------------------------

 

ANALYSIS

 

This bill adds a new qualifying medical condition for the purposes of receiving cannabis for therapeutic use.

 

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

 

Explanation: Matter added to current law appears in bold italics.

Matter removed from current law appears [in brackets and struckthrough.]

Matter which is either (a) all new or (b) repealed and reenacted appears in regular type.

17-0516

01/04

 

STATE OF NEW HAMPSHIRE

 

In the Year of Our Lord Two Thousand Seventeen

 

AN ACT relative to the law regarding therapeutic use of cannabis.

 

Be it Enacted by the Senate and House of Representatives in General Court convened:

 

1  Use of Cannabis for Therapeutic Purposes.  Amend RSA 126-X:1, IX(a) to read as follows:

IX.(a)(1)  "Qualifying medical condition'' means the presence of:

[(1)] (A)  Cancer, glaucoma, positive status for human immunodeficiency virus, acquired immune deficiency syndrome, hepatitis C currently receiving antiviral treatment, amyotrophic lateral sclerosis, muscular dystrophy, Crohn's disease, multiple sclerosis, chronic pancreatitis, spinal cord injury or disease, traumatic brain injury, epilepsy, lupus, Parkinson's disease, Alzheimer's disease, ulcerative colitis, or one or more injuries that significantly interferes with daily activities as documented by the patient's provider; and

[(2)] (B)  A severely debilitating or terminal medical condition or its treatment that has produced at least one of the following: elevated intraocular pressure, cachexia, chemotherapy-induced anorexia, wasting syndrome, agitation of Alzheimer's disease, severe pain that has not responded to previously prescribed medication or surgical measures or for which other treatment options produced serious side effects, constant or severe nausea, moderate to severe vomiting, seizures, or severe, persistent muscle spasms[.]; or

(2)  "Qualifying medical condition" also means severe pain that has not responded to previously prescribed medication or surgical measures or for which other treatment options produced serious side effects.

2  Effective Date.  This act shall take effect 60 days after its passage.

Links

SB15 at GenCourtMobile

Action Dates

Date Body Type
Jan. 10, 2017 Senate Hearing
Jan. 19, 2017 Senate Floor Vote
March 21, 2017 House Hearing
March 22, 2017 House Exec Session
April 20, 2017 House Floor Vote

Bill Text Revisions

SB15 Revision: 1728 Date: April 20, 2017, 1:27 p.m.
SB15 Revision: 1729 Date: Jan. 24, 2017, 10:48 a.m.

Docket

Date Status
Jan. 5, 2017 To Be Introduced 01/05/2017 and Referred to Health and Human Services; SJ 4
Jan. 10, 2017 Hearing: 01/10/2017, Room 101, LOB, 01:30 pm; SC 5
Jan. 19, 2017 Committee Report: Ought to Pass, 01/19/2017; SC 6
Jan. 19, 2017 Sen. Bradley Offered Floor Amendment # 2017-0048s; 01/19/2017; SJ 4
Jan. 19, 2017 Sen. Bradley Withdraws Floor Amendment 2017-0048s; 01/19/2017; SJ 4
Jan. 19, 2017 Ought to Pass: MA, VV; OT3rdg; 01/19/2017; SJ 4
Feb. 16, 2017 Introduced 02/16/2017 and referred to Health, Human Services and Elderly Affairs HJ 8 P. 44
March 21, 2017 Public Hearing: 03/21/2017 10:00 AM LOB 205
March 22, 2017 Executive Session: 03/22/2017 09:00 AM LOB 205
April 20, 2017 Committee Report: Ought to Pass for 04/20/2017 (Vote 17-2; RC) HC 20 P. 8
April 20, 2017 Ought to Pass: MA VV 04/20/2017 HJ 14 P. 10
May 4, 2017 Reconsider SB 15 (Rep. Cushing): MA VV 05/04/2017
May 4, 2017 Lay on Table (Rep. Kotowski): MA VV 05/04/2017
Died on Table